Skip to search formSkip to main contentSkip to account menu

AH 11110A

Known as: 1-(biphenyl-2-yloxy)-4-imino-4-piperidin-1-yl-butan-2-ol, AH-11110A, AH11110A 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

IminesPiperidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Chlorine Para-Substitution of 1-Phenylethanol: Resonant Photoionization Spectroscopy and Quantum Chemical Calculations of Hydrated and Diastereomeric Complexes.
The conformational landscape of (S)-1-(4-chlorophenyl)ethanol, its monohydrated complex, and its diastereomeric adducts with R… 
2010
2010
Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypes.
2008
2008
Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease.
1 Alpha1-Adrenoceptor (alpha1-AR) subtypes were characterized in isolated omental arteries obtained after abdominal surgery in… 
2005
2005
Chloroethylclonidine reveals that alpha (1 A)-adrenoceptors mediate contraction in aorta of alpha (1 D)-adrenoceptor knockout mice.
1 We have characterized the alpha(1)-adrenoceptor subtypes present in isolated aorta of the alpha(1D)-adrenoceptor knockout (KO… 
2004
2004
Essential oils of mongolian plants
Summary1. The following compounds have been isolated by gas-liquid chromatography from the essential oil ofArtemisia rutifolia… 
2003
2003
Regulation of alpha(1)-adrenoceptor-linked phosphoinositide metabolism in cultured glia: involvement of protein phosphatases and kinases.
2001
2001
Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors.
The potency of the putatively alpha(1B)-adrenoceptor selective drug, 1-[biphenyl-2-yloxy]-4-imino-4-piperidin-1-yl-butan-2-ol… 
1999
1999
Inverse Agonism and Neutral Antagonism at a 1 aand a 1 b-Adrenergic Receptor Subtypes
We have characterized the pharmacological antagonism, i.e., neutral antagonism or inverse agonism, displayed by a number of a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)